Pneumonic epidemic situation still is in new coronal global indulge in wilful persecution, make an appointment with news of network of official of university of writing · suddenly Pu Jinsi according to the United States, up to on June 30, the whole world already had 1000 much people to affect new coronal pneumonic, dead number already exceeded 500 thousand person. British premier Boris Johnson ever expressed · : "Terminative new coronal is pneumonic epidemic situation is exclusive and long-term effective solution is to develop an effective vaccine and treatment. |
According to the United States " news weekly " the website reported on June 25, world Health Organization confirmed recently, global researcher is developing vaccine of virus of at least 142 kinds of new coronals, wait for a country by China, United States, England and Germany among them the scientist develops 10 a variety of awaiting choose vaccine to be being accepted clinical evaluate, additionally 120 a variety of is in clinical before research phase.
So, is effective vaccine apart from us to still have many far? England " daily telecommunications signs up for " and " news weekly " the website listed for us recently Europe (basically be England) develop progress case with American vaccine.
Europe: Ying Deling runs
On June 13, europe is multilateral with Si Likang of A of Swedish joint ventures pharmacy company announces, xiang Ou allied country home is offerred amount to 400 million effectiveness to have not obtain the AZD1222 vaccine that confirm, offer 100 million to England among them. AZD1222 vaccine is mixed by institute of accept of British Oxford Zhan group of Oxford vaccine research is developed hand in hand.
Company of A Si Likang makes a statement say: "Of AZD1222 vaccine 1 period / 2 period clinical trial was started on April 23, use at evaluating former sex of vaccinal security, immunity and effectiveness, many 1000 18, healthy volunteer of 55 years old is in England the south vaccination of many tests center. Many 1000 18, healthy volunteer of 55 years old is in England the south vaccination of many tests center..
Occupy network of news of American cable television to reported on June 22, asilikang company general develops this vaccine at was in England this year in August 3 period clinical trial, this is the last pace before vaccine obtains superintendency layer approval to appear on the market.
On June 15, british empire technical institute announces, project of research and development of vaccine of this school new coronal begins Yu Benzhou clinical trial. It is reported, vaccine of this new coronal is based on ego enlarge to add model ribonucleic acid technology, shortly will begin 1 period and 2 period in clinical trial, add up to can have 300 ages to upright at 18, healthy volunteer have an inoculation of 70 years old is awaited this kind choose vaccine, each two agents. The group will begin later on this year more large-scale 3 period clinical trial, number of recruit health volunteer will reach about 6000 people. This research of Caesarean technical institute got British government of 41 million pound aid financially.
The name of a river in Shaanxi and Henan provinces of A of England of British commerce secretary overcomes horse of · Xia Er to announced a few days ago, the government will allocate funds 84 million pound, work in order to accelerate the vaccinal research and development that Oxford and Caesarean technical institute are beginning at present.
In addition, to help England mass production is vaccinal, the month on Xiaerma announces England will build first vaccine to produce innovation center in Oxfordshire, this center predicts Spring 2021 complete.
According to " news weekly " report, company of technology of substance of German illicit life " heal is vaccinal " (CureVac) company announced recently, its are new coronal virus is awaited choose vaccine to already undertook permissibly 1 period clinical trial, 168 when attend clinical trial suffer the person that try to will be in respectively Germany and Belgian vaccination. German government already invested 269 million pound to this company, aid financially its to begin the clinical trial of vaccine of coronal shape virus.
Lan Su history overcomes British arrowroot and company of French Sai Nuofei also is developing new coronal hand in hand pneumonic vaccine, the test is developed before planning to be by 2020.
The United States: Progress is rapid
According to network of news of American cable television (CNN)6 reports 22 days month, the United States besides contributive 1.2 billion dollar, with Asilikang the company signs an agreement, outside manufacturing 400 million vaccine that developing by Oxford, still funded the research and development of vaccine of additionally 6 new coronals.
The vaccinal MRNA-1273 that by the United States Mo Dena company develops began to undertake in the United States in March this year 1 period clinical trial, this experiment is mixed by American country allergy contagion institute (NIAID) is aided financially, american government is aided financially to what its offerred 456 million dollar. Anthony of NIAID strong point the middle ten days of a month confirms · Fu Ji this month, vaccinal research and development " progress is very rapid " . Mo Dena company will begin this vaccine in July this year 3 period experiment. He says: "If everything is successful, we hope to be in deep this year autumn perhaps obtain before Chu Dong (vaccinal) effectiveness signal, I feel the vaccine that obtains enough yield to December is not an incredible story. I feel the vaccine that obtains enough yield to December is not an incredible story..
Occupy message of Reuter, Afp additionally, strong unripe company also decides the United States vaccine of new coronal virus will begin in September 3 period human body experiments, hope vaccine can be used in meet an urgent need of the investment at the beginning of 2021, and experiment of general and vaccinal experience, approval and production each phase, need investment of 18 months ability to use at least. It is reported, this year in January, strong unripe company and college of medicine of haing Buddha university cooperate, with development the technology that Aibola uses when virus is vaccinal studies new coronal virus is vaccinal, american government is aided financially to what gave birth to a company by force to offer 430 million dollar.
American Nuo covers with tiles the company started Wakesi in May of NVX-CoV2373 vaccine 1 period experiment. The company releases statement to say, 1 period the preliminary result of the experiment will be announced in July, 2 period the experiment will be inspected 1 period experimental result is started as soon as possible, at present 3 period the experiment has not include program.
And data studies before what according to Nuoweiao pharmacy company announced INO-4800 vaccine in May is clinical, according to Nuoweiao the company shows, predicting at latest announces first phase by June the preliminary safety of clinical trial and immune reaction data, 2 period and 3 period clinical trial will be inspected examine and approve a circumstance to be in 7, undertook in August.
The army researcher of institute of army of the heart in · of American Wo Er spy decided vaccinal and archetypal individual plant in June, experiment of vaccinal human body predicts to was started in Washington special zone in July, vaccinal job predicts to will begin in September.
In addition, company of silent gram pharmacy obtained American government of 38 million dollar aid financially, use production Aibola's vaccinal technology, development goes virus of a new coronal, had not begun to have human body at present clinical trial. (reporter Liu Xia)